Editor's Note HST Pathways’ most recent industry report, discussed on the Advancing Surgical Care Podcast by HST CEO David Thawley and Bill Prentice, CEO of the Ambulatory Surgery Center Association (ASCA), offers insights into cardiology and orthopedic procedures done in ambulatory surgery centers (ASCs) in 2024, Ambulatory Surgery Center News…

Read More

Editor's Note A wearable smart t-shirt that remotely monitors vital signs helped patients go home earlier and feel safer after robot-assisted urological cancer surgery, according to a March 21 article in Medical Xpress. The article details a pilot study, presented at the European Association of Urology Congress in Madrid, Spain,…

Read More

Editor's Note Endovascular devices used to block aneurysm blood flow are the subject of the latest recall to be designated Class 1—the most severe designation indicating serious risk of injury or death—by the US Food and Drug Administration (FDA). As detailed in the agency’s March 18 announcement, Medtronic Neurovascular is…

Read More

Editor's Note Miniaturized pacemakers implanted in neonates and infants have demonstrated reliable performance for up to two years, with no unexpected device failures, according to a March 11 article in Healio. The research, published in Circulation: Arrhythmia and Electrophysiology, suggests that these modified pacemakers could offer a viable alternative for…

Read More

Editor's Note An Australian man lived for 100 days with an artificial titanium heart, the longest duration recorded for a patient using the device, according to a March 12 report from CNN. The breakthrough marks a significant step toward using total artificial hearts as a long-term solution for patients with…

Read More

Editor's Note Surgeons recently performed open-heart surgery on an infant during a C-section to correct a congenital heart defect, according to a February 25 brief from the American College of Surgeons. Led by Dr. Sameh Said at Maria Fareri Children's Hospital, a team of specialists conducted the procedure on a…

Read More

Editor’s Note The US Food and Drug Administration (FDA) has designated Boston Scientific Corporation’s recall of Accolade Pacemaker devices a Class 1, the most severe category indicating serious risk of injury or death. According to the agency’s February 21 announcement, the recall was motivated by a manufacturing issue that could…

Read More

Editor's Note Patients aged 50 to 70 undergoing heart valve replacement may benefit from mechanical valves over biological ones, according to a new study from the University of Bristol. Healthcare-in-Europe.com reported the news February 13. As detailed in the article, short-term outcomes between the two options were similar. However, mechanical…

Read More

Editor's Note Coronary artery bypass graft (CABG) surgery and transcatheter aortic valve replacement (TAVR) generate the highest overall financial returns for US hospitals, despite not being the most profitable per procedure, according to a February 13 report in Cardiovascular Business. The article covers an analysis of Medicare data, published in…

Read More

Editor’s Note At the Society of Thoracic Surgeons (STS) annual meeting, experts urged cardiac surgeons to become more engaged in tricuspid valve treatment before transcatheter options gain too much traction according to a January 26 report in MedPage Today. With new transcatheter devices gaining FDA approval and the Centers for…

Read More